FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

11478111000001103: Cabergoline 2mg tablets 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
42120401000001110 Cabergoline 2mg tablets 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
42120501000001114 Cabergoline 2mg tablets 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cabergoline 2mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets 30 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets 30 tablet Is pack of Product containing precisely cabergoline 2 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets 30 tablet Has active ingredient Cabergoline false Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets 30 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets 30 tablet Has VMP Product containing precisely cabergoline 2 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets 30 tablet Has specific active ingredient Cabergoline true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cabaser 2mg tablets (Waymade Healthcare Plc) 30 tablet Is a True Cabergoline 2mg tablets 30 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start